VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 111 filers reported holding VOYAGER THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,540,871 | +124.3% | 198,822 | +19.5% | 0.00% | +200.0% |
| Q2 2021 | $687,000 | -59.8% | 166,330 | -54.1% | 0.00% | -66.7% |
| Q1 2021 | $1,707,000 | +42.6% | 362,438 | +116.6% | 0.00% | +50.0% |
| Q4 2020 | $1,197,000 | +332.1% | 167,355 | +545.7% | 0.00% | – |
| Q3 2020 | $277,000 | -57.5% | 25,920 | -49.7% | 0.00% | -100.0% |
| Q2 2020 | $651,000 | +21.5% | 51,564 | -11.9% | 0.00% | 0.0% |
| Q1 2020 | $536,000 | -45.5% | 58,530 | -16.9% | 0.00% | 0.0% |
| Q4 2019 | $983,000 | -26.7% | 70,456 | -9.6% | 0.00% | -50.0% |
| Q3 2019 | $1,341,000 | +139.0% | 77,905 | +278.1% | 0.00% | +100.0% |
| Q2 2019 | $561,000 | +18.9% | 20,606 | -16.5% | 0.00% | 0.0% |
| Q1 2019 | $472,000 | +1.3% | 24,665 | -50.3% | 0.00% | 0.0% |
| Q4 2018 | $466,000 | +29.8% | 49,589 | +161.3% | 0.00% | – |
| Q3 2018 | $359,000 | -21.3% | 18,981 | -18.6% | 0.00% | – |
| Q2 2018 | $456,000 | – | 23,327 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $45,697,000 | 3.92% |
| ARMISTICE CAPITAL, LLC | 3,392,000 | $24,253,000 | 0.82% |
| Bellevue Group AG | 2,712,083 | $19,391,000 | 0.22% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 141,924 | $1,015,000 | 0.17% |
| XTX MARKETS LLC | 10,578 | $76,000 | 0.16% |
| Aevitas Wealth Management, Inc. | 22,150 | $158,000 | 0.12% |
| Virtus ETF Advisers LLC | 35,079 | $251,000 | 0.10% |
| HITE Hedge Asset Management LLC | 29,357 | $210,000 | 0.05% |
| LINCOLN CAPITAL CORP | 10,000 | $72,000 | 0.05% |
| CIM INVESTMENT MANAGEMENT INC | 18,745 | $134,000 | 0.04% |